Conference Reporter

Advertisment
Browse Conference Reporter by Category
Conference Reporter in Melanoma to Cover Key Topics Being Presented at the 2024 ASCO Annual Meeting
Melanoma

Conference Reporter in Melanoma to Cover Key Topics Being Presented at the 2024 ASCO Annual Meeting

conference reporter
Challenging Cases in Psoriasis
Plaque Psoriasis

Challenging Cases in Psoriasis

conference reporter
By Bruce E. Strober, MD, PhD
Conference Reporter in HR+ HER2- Breast Cancer to Cover Key Topics Being Presented at the 2024 ASCO Annual Meeting
HR+ HER2- Breast Cancer

Conference Reporter in HR+ HER2- Breast Cancer to Cover Key Topics Being Presented at the 2024 ASCO Annual Meeting

conference reporter
By William J. Gradishar, MD, FACP; Sara M. Tolaney, MD, MPH
Conference Reporter in IgAN & C3G to Cover Key Topics Being Presented at the NKF SCM24
IgAN & C3G

Conference Reporter in IgAN & C3G to Cover Key Topics Being Presented at the NKF SCM24

conference reporter
Conference Reporter in Systemic Lupus Erythematosus to Cover Key Topics Being Presented at CCR East and CCR West 2024
Systemic Lupus Erythematosus

Conference Reporter in Systemic Lupus Erythematosus to Cover Key Topics Being Presented at CCR East and CCR West 2024

conference reporter
By Joan T. Merrill, MD; George C. Tsokos, MD
Immunotherapy for Food Allergies: New Methods and Delivery Options
Food Allergies

Immunotherapy for Food Allergies: New Methods and Delivery Options

conference reporter
By Ruchi Gupta, MD, MPH
Food and Environmental Allergy Interactions: Understanding Pollen Food Allergy Syndrome
Food Allergies

Food and Environmental Allergy Interactions: Understanding Pollen Food Allergy Syndrome

conference reporter
By Ruchi Gupta, MD, MPH
The Primary Prevention of Food Allergies and the Role of Early Exposure
Food Allergies

The Primary Prevention of Food Allergies and the Role of Early Exposure

conference reporter
By Ruchi Gupta, MD, MPH
Challenges in the Management of Genital Psoriasis
Plaque Psoriasis

Challenges in the Management of Genital Psoriasis

conference reporter
By Bruce E. Strober, MD, PhD
The Role of Biologic Therapy in IgE-Mediated Food Allergies
Food Allergies

The Role of Biologic Therapy in IgE-Mediated Food Allergies

conference reporter
By Edwin Kim, MD, MS
Surveillance After Complete Resection of Gastroenteropancreatic Neuroendocrine Tumors
Gastroenteropancreatic Neuroendocrine Tumors

Surveillance After Complete Resection of Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Timothy J. Hobday, MD
The Importance of Shared Decision Making in the Management of Food Allergies
Food Allergies

The Importance of Shared Decision Making in the Management of Food Allergies

conference reporter
By Edwin Kim, MD, MS
Gastroenteropancreatic Neuroendocrine Tumors: Clinical Trials in Progress
Gastroenteropancreatic Neuroendocrine Tumors

Gastroenteropancreatic Neuroendocrine Tumors: Clinical Trials in Progress

conference reporter
By Timothy J. Hobday, MD
The Rapidly Changing Treatment Landscape of Psoriasis and Psoriatic Arthritis
Plaque Psoriasis

The Rapidly Changing Treatment Landscape of Psoriasis and Psoriatic Arthritis

conference reporter
By Steven R. Feldman, MD, PhD
Plaque Psoriasis in the Real-World Pediatric Population
Plaque Psoriasis

Plaque Psoriasis in the Real-World Pediatric Population

conference reporter
By Bruce E. Strober, MD, PhD
Potential Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors
Gastroenteropancreatic Neuroendocrine Tumors

Potential Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Timothy J. Hobday, MD
Diagnostic Advancements in Food Allergies: Expanding Beyond the Use of the Oral Food Challenge
Food Allergies

Diagnostic Advancements in Food Allergies: Expanding Beyond the Use of the Oral Food Challenge

conference reporter
By Edwin Kim, MD, MS
Health-Related Quality of Life in Patients With Plaque Psoriasis
Plaque Psoriasis

Health-Related Quality of Life in Patients With Plaque Psoriasis

conference reporter
By Steven R. Feldman, MD, PhD
Treating Midgut vs Non-Midgut Gastroenteropancreatic Neuroendocrine Tumors
Gastroenteropancreatic Neuroendocrine Tumors

Treating Midgut vs Non-Midgut Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Jonathan R. Strosberg, MD
Screening Patients With Plaque Psoriasis for Biologic Treatment
Plaque Psoriasis

Screening Patients With Plaque Psoriasis for Biologic Treatment

conference reporter
By Steven R. Feldman, MD, PhD
Gastric Neuroendocrine Tumors: Updates and Perspectives
Gastroenteropancreatic Neuroendocrine Tumors

Gastric Neuroendocrine Tumors: Updates and Perspectives

conference reporter
By Jonathan R. Strosberg, MD
Conference Reporter in Food Allergies to Cover Key Topics Being Presented at the AAAAI 2024
Food Allergies

Conference Reporter in Food Allergies to Cover Key Topics Being Presented at the AAAAI 2024

conference reporter
By Ruchi Gupta, MD, MPH; Edwin Kim, MD, MS
Peptide Receptor Radionuclide Therapy for Neuroendocrine Neoplasms
Gastroenteropancreatic Neuroendocrine Tumors

Peptide Receptor Radionuclide Therapy for Neuroendocrine Neoplasms

conference reporter
By Jonathan R. Strosberg, MD
Hematologic Outcomes in Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria

Hematologic Outcomes in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Ronald S. Go, MD
Infection Risk and Vaccination Response in Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria

Infection Risk and Vaccination Response in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Ronald S. Go, MD
Updates on Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria

Updates on Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Ronald S. Go, MD
Revisiting the Distinct Phenotypic Categories of Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria

Revisiting the Distinct Phenotypic Categories of Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Jaroslaw P. Maciejewski, MD, PhD, FACP
Novel Complement-Blocking Strategies in Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria

Novel Complement-Blocking Strategies in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Jaroslaw P. Maciejewski, MD, PhD, FACP
Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2024 ASCO-GI Cancers Symposium
Gastroenteropancreatic Neuroendocrine Tumors

Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2024 ASCO-GI Cancers Symposium

conference reporter
By Timothy J. Hobday, MD; Jonathan R. Strosberg, MD
Clonal Trajectories and Clonal Evolution in Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria

Clonal Trajectories and Clonal Evolution in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Jaroslaw P. Maciejewski, MD, PhD, FACP
Living With Fatigue From Glomerular Disease
IgAN & C3G

Living With Fatigue From Glomerular Disease

conference reporter
By Carla M. Nester, MD, MSA, FASN
Conference Highlights: Toward Disease Modification in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus

Conference Highlights: Toward Disease Modification in Systemic Lupus Erythematosus

conference reporter
By Anca D. Askanase, MD, MPH
Conference Reporter in Plaque Psoriasis to Cover Key Topics Being Presented at the Maui Derm Hawaii 2024 Meeting
Plaque Psoriasis

Conference Reporter in Plaque Psoriasis to Cover Key Topics Being Presented at the Maui Derm Hawaii 2024 Meeting

conference reporter
By Steven R. Feldman, MD, PhD; Bruce E. Strober, MD, PhD
The Emerging Role of JAK Inhibitors in the Management of Psoriasis
Plaque Psoriasis

The Emerging Role of JAK Inhibitors in the Management of Psoriasis

conference reporter
By Bruce E. Strober, MD, PhD
Role of Cytokines in Immunoglobulin A Nephropathy: Pathogenesis and Novel Therapies
IgAN & C3G

Role of Cytokines in Immunoglobulin A Nephropathy: Pathogenesis and Novel Therapies

conference reporter
By Carla M. Nester, MD, MSA, FASN
Real-World Data on Systemic Lupus Erythematosus
Systemic Lupus Erythematosus

Real-World Data on Systemic Lupus Erythematosus

conference reporter
By Maureen A. McMahon, MD
Clinical Insights Into the Topical Treatment of Psoriasis
Plaque Psoriasis

Clinical Insights Into the Topical Treatment of Psoriasis

conference reporter
By Bruce E. Strober, MD, PhD
Controversies in Complement 3 Glomerulopathy
IgAN & C3G

Controversies in Complement 3 Glomerulopathy

conference reporter
By Carla M. Nester, MD, MSA, FASN
Update on Systemic Lupus Erythematosus Biomarkers and Prognostication
Systemic Lupus Erythematosus

Update on Systemic Lupus Erythematosus Biomarkers and Prognostication

conference reporter
By Vasileios C. Kyttaris, MD
Real-World Experience With IL-17 and IL-23 Inhibitors for Plaque Psoriasis
Plaque Psoriasis

Real-World Experience With IL-17 and IL-23 Inhibitors for Plaque Psoriasis

conference reporter
By Boni E. Elewski, MD
Personalizing Therapy for Patients With Gastroenteropancreatic Neuroendocrine Tumors
Gastroenteropancreatic Neuroendocrine Tumors

Personalizing Therapy for Patients With Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Thorvadur R. Halfdanarson, MD
Challenges in Managing Complement 3 Glomerulopathy
IgAN & C3G

Challenges in Managing Complement 3 Glomerulopathy

conference reporter
By Andrew S. Bomback, MD, MPH
Conference Reporter in Paroxysmal Nocturnal Hemoglobinuria to Cover Key Topics Being Presented at the 65th ASH Annual Meeting and Exposition
Paroxysmal Nocturnal Hemoglobinuria

Conference Reporter in Paroxysmal Nocturnal Hemoglobinuria to Cover Key Topics Being Presented at the 65th ASH Annual Meeting and Exposition

conference reporter
By Ronald S. Go, MD; Jaroslaw P. Maciejewski, MD, PhD, FACP
Gastroenteropancreatic Neuroendocrine Tumors: Clinical Trials and Future Directions
Gastroenteropancreatic Neuroendocrine Tumors

Gastroenteropancreatic Neuroendocrine Tumors: Clinical Trials and Future Directions

conference reporter
By Thorvadur R. Halfdanarson, MD
The Evolving Treatment Landscape for Immunoglobulin A Nephropathy
IgAN & C3G

The Evolving Treatment Landscape for Immunoglobulin A Nephropathy

conference reporter
By Andrew S. Bomback, MD, MPH
Psoriasis in Patients With Skin of Color: Diagnosis and Management Considerations
Plaque Psoriasis

Psoriasis in Patients With Skin of Color: Diagnosis and Management Considerations

conference reporter
By Boni E. Elewski, MD
Interdisciplinary Perspectives on Grade Evolution in Gastroenteropancreatic Neuroendocrine Tumors
Gastroenteropancreatic Neuroendocrine Tumors

Interdisciplinary Perspectives on Grade Evolution in Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Jennifer R. Eads, MD
Exploring the Therapeutic Landscape for Complement-Mediated Kidney Diseases
IgAN & C3G

Exploring the Therapeutic Landscape for Complement-Mediated Kidney Diseases

conference reporter
By Andrew S. Bomback, MD, MPH
Choosing Systemic Agents for Psoriasis: What Clinicians Need to Know Now
Plaque Psoriasis

Choosing Systemic Agents for Psoriasis: What Clinicians Need to Know Now

conference reporter
By Boni E. Elewski, MD
Autoimmunity and Autoantibody Profiles in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus

Autoimmunity and Autoantibody Profiles in Systemic Lupus Erythematosus

conference reporter
By Vasileios C. Kyttaris, MD
Advancements in Systemic Lupus Erythematosus: Entering a New Era
RheumatologySystemic Lupus Erythematosus

Advancements in Systemic Lupus Erythematosus: Entering a New Era

conference reporter
By Maureen A. McMahon, MD
Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2023 NANETS Multidisciplinary NET Medical Symposium
Gastroenteropancreatic Neuroendocrine Tumors

Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2023 NANETS Multidisciplinary NET Medical Symposium

conference reporter
By Jennifer R. Eads, MD; Thorvadur R. Halfdanarson, MD
Conference Reporter in Plaque Psoriasis to Cover Key Topics Being Presented at the 2023 Fall Clinical Dermatology Conference
Plaque Psoriasis

Conference Reporter in Plaque Psoriasis to Cover Key Topics Being Presented at the 2023 Fall Clinical Dermatology Conference

conference reporter
By Boni E. Elewski, MD; Bruce E. Strober, MD, PhD
Transitioning From a Conventional Imaging Paradigm to a Next-Generation Imaging Paradigm
Metastatic Prostate Cancer

Transitioning From a Conventional Imaging Paradigm to a Next-Generation Imaging Paradigm

conference reporter
By Tom Iarocci, MD
Conference Reporter and Highlight Article: Important Aspects of Care in Advanced Prostate Cancer
Metastatic Prostate Cancer

Conference Reporter and Highlight Article: Important Aspects of Care in Advanced Prostate Cancer

conference commentary
By Tanya B. Dorff, MD; Tom Iarocci, MD
Conference Reporter and Highlight Article: Spotlight on Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy
Metastatic Prostate Cancer

Conference Reporter and Highlight Article: Spotlight on Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy

conference commentary
By Scott T. Tagawa, MD, MS, FACP; Tom Iarocci, MD
Patient Selection and Treatment Personalization With Prostate-Specific Membrane Antigen–Directed  Radioligand Therapy
Metastatic Prostate Cancer

Patient Selection and Treatment Personalization With Prostate-Specific Membrane Antigen–Directed Radioligand Therapy

conference reporter
By Tom Iarocci, MD
Thinking Differently About Breast Cancer in Young Women
HR+ HER2- Breast Cancer

Thinking Differently About Breast Cancer in Young Women

conference reporter
By Ian Krop, MD, PhD
CDK4/6 Inhibition and Endocrine Resistance in Advanced HR+ HER2- Breast Cancer
HR+ HER2- Breast Cancer

CDK4/6 Inhibition and Endocrine Resistance in Advanced HR+ HER2- Breast Cancer

conference reporter
By Ian Krop, MD, PhD
Updates on Prostate-Specific Membrane Antigen Positron Emission Tomography
Metastatic Prostate Cancer

Updates on Prostate-Specific Membrane Antigen Positron Emission Tomography

conference reporter
By Tom Iarocci, MD
Selective Estrogen Receptor Degraders and Other Novel Agents in Breast Cancer: Where Do We Stand?
HR+ HER2- Breast Cancer

Selective Estrogen Receptor Degraders and Other Novel Agents in Breast Cancer: Where Do We Stand?

conference reporter
By Sara M. Tolaney, MD, MPH
Chronic Myeloid Leukemia at EHA2023: Conference Roundup
Chronic Myeloid Leukemia

Chronic Myeloid Leukemia at EHA2023: Conference Roundup

conference reporter
By Daniel J. DeAngelo, MD, PhD
CDK4/6 Inhibition in Advanced HR+ HER2- Breast Cancer
HR+ HER2- Breast Cancer

CDK4/6 Inhibition in Advanced HR+ HER2- Breast Cancer

conference reporter
By Sara M. Tolaney, MD, MPH
Treatment-Free Remission in Chronic Myeloid Leukemia: How to Optimize Eligibility and Improve Success Rates
Chronic Myeloid Leukemia

Treatment-Free Remission in Chronic Myeloid Leukemia: How to Optimize Eligibility and Improve Success Rates

conference reporter
By Elias Jabbour, MD
Gaining Experience With Prostate-Specific Membrane Antigen–Directed Radioligand Therapy
Metastatic Prostate Cancer

Gaining Experience With Prostate-Specific Membrane Antigen–Directed Radioligand Therapy

conference reporter
By Tom Iarocci, MD
Conference Reporter in Metastatic Prostate Cancer to Cover Key Topics Being Presented at SNMMI 2023
Metastatic Prostate Cancer

Conference Reporter in Metastatic Prostate Cancer to Cover Key Topics Being Presented at SNMMI 2023

conference reporter
By Tom Iarocci, MD
Late-line Treatment in Chronic-Phase Chronic Myeloid Leukemia
Chronic Myeloid Leukemia

Late-line Treatment in Chronic-Phase Chronic Myeloid Leukemia

conference reporter
By Elias Jabbour, MD
Systemic Lupus Erythematosus Roundup at Eastern Rheumatology Congress
Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Roundup at Eastern Rheumatology Congress

conference reporter
By Maureen A. McMahon, MD
Addressing Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus

Addressing Refractory Systemic Lupus Erythematosus

conference reporter
By Anca D. Askanase, MD, MPH
Glomerular Disease: Conference Roundup on Immunoglobulin A Nephropathy, Complement 3 Glomerulopathy, and Focal Segmental Glomerulosclerosis
IgAN & C3G

Glomerular Disease: Conference Roundup on Immunoglobulin A Nephropathy, Complement 3 Glomerulopathy, and Focal Segmental Glomerulosclerosis

conference reporter
By Samir V. Parikh, MD, FASN
Conference Reporter in HR+ HER2- Breast Cancer to Cover Key Topics Being Presented at the 2023 ASCO Annual Meeting
HR+ HER2- Breast Cancer

Conference Reporter in HR+ HER2- Breast Cancer to Cover Key Topics Being Presented at the 2023 ASCO Annual Meeting

conference reporter
By Ian Krop, MD, PhD; Sara M. Tolaney, MD, MPH
New Studies and Emerging Data on Complement-Driven Kidney Diseases
IgAN & C3G

New Studies and Emerging Data on Complement-Driven Kidney Diseases

conference reporter
By Samir V. Parikh, MD, FASN
Systemic Lupus Erythematosus: Response to Treatment With Newer Therapies
Systemic Lupus Erythematosus

Systemic Lupus Erythematosus: Response to Treatment With Newer Therapies

conference reporter
By Vasileios C. Kyttaris, MD
Case for Consideration: Glomerular Diseases at a National Kidney Disease Conference
IgAN & C3G

Case for Consideration: Glomerular Diseases at a National Kidney Disease Conference

conference reporter
By Carla M. Nester, MD, MSA, FASN
Conference Reporter in Chronic Myeloid Leukemia to Cover Key Topics Being Presented at EHA2023 Hybrid Congress
Chronic Myeloid Leukemia

Conference Reporter in Chronic Myeloid Leukemia to Cover Key Topics Being Presented at EHA2023 Hybrid Congress

conference reporter
By Daniel J. DeAngelo, MD, PhD; Elias Jabbour, MD
Unmet Needs and Targeted Treatments for Glomerular Diseases
IgAN & C3G

Unmet Needs and Targeted Treatments for Glomerular Diseases

conference reporter
By Carla M. Nester, MD, MSA, FASN
Improving Outcomes in Complement-Mediated Kidney Disease
IgAN & C3G

Improving Outcomes in Complement-Mediated Kidney Disease

conference reporter
By Andrew S. Bomback, MD, MPH
Immunoglobulin A Nephropathy: Challenges and Emerging Treatments
IgAN & C3G

Immunoglobulin A Nephropathy: Challenges and Emerging Treatments

conference reporter
By Andrew S. Bomback, MD, MPH
Conference Reporter in Systemic Lupus Erythematosus to Cover Key Topics Being Presented at CCR East, CCR West, and ACR Convergence 2023
Systemic Lupus Erythematosus

Conference Reporter in Systemic Lupus Erythematosus to Cover Key Topics Being Presented at CCR East, CCR West, and ACR Convergence 2023

conference reporter
By Anca D. Askanase, MD, MPH; Maureen A. McMahon, MD; Vasileios C. Kyttaris, MD
Conference Reporter in IgAN and C3G – Complement Mediated Kidney Diseases to Cover Key Topics Being Presented at the NKF 2023 Spring Clinical Meetings
IgAN & C3G

Conference Reporter in IgAN and C3G – Complement Mediated Kidney Diseases to Cover Key Topics Being Presented at the NKF 2023 Spring Clinical Meetings

conference reporter
By Andrew S. Bomback, MD, MPH; Carla M. Nester, MD, MSA, FASN; Samir V. Parikh, MD, FASN
Treatment-Free Remission in Chronic Myeloid Leukemia
Chronic Myeloid Leukemia

Treatment-Free Remission in Chronic Myeloid Leukemia

conference reporter
By Michael J. Mauro, MD
Chronic Myeloid Leukemia: Unmet Needs and Trials in Progress
Chronic Myeloid Leukemia

Chronic Myeloid Leukemia: Unmet Needs and Trials in Progress

conference reporter
By Michael J. Mauro, MD
Next-Generation Complement Inhibitors for Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria

Next-Generation Complement Inhibitors for Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Jaroslaw P. Maciejewski, MD, PhD, FACP
Flow Cytometry and Clonal Considerations in Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria

Flow Cytometry and Clonal Considerations in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Jaroslaw P. Maciejewski, MD, PhD, FACP
Later-line Treatments in Chronic Myeloid Leukemia
Chronic Myeloid Leukemia

Later-line Treatments in Chronic Myeloid Leukemia

conference reporter
By Neil P. Shah, MD, PhD
Future Directions for Paroxysmal Nocturnal Hemoglobinuria Treatment
Paroxysmal Nocturnal Hemoglobinuria

Future Directions for Paroxysmal Nocturnal Hemoglobinuria Treatment

conference reporter
By Carlos M. de Castro III, MD
Extravascular Hemolysis and Residual Anemia in Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria

Extravascular Hemolysis and Residual Anemia in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Carlos M. de Castro III, MD
Tolerability of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Chronic Myeloid Leukemia

Tolerability of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

conference reporter
By Neil P. Shah, MD, PhD
Evolving Practices in the Treatment of Chronic Myeloid Leukemia
Chronic Myeloid Leukemia

Evolving Practices in the Treatment of Chronic Myeloid Leukemia

conference reporter
By Hagop M. Kantarjian, MD
Complications and Comorbidities in Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria

Complications and Comorbidities in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Ronald S. Go, MD
Paroxysmal Nocturnal Hemoglobinuria: Initial Presentation, Diagnosis, and Management
Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria: Initial Presentation, Diagnosis, and Management

conference reporter
By Ronald S. Go, MD
BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Current Landscape
Chronic Myeloid Leukemia

BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Current Landscape

conference reporter
By Hagop M. Kantarjian, MD
Conference Reporter in Paroxysmal Nocturnal Hemoglobinuria to Cover Key Topics Being Presented at the 64th ASH Annual Meeting and Exposition
Paroxysmal Nocturnal Hemoglobinuria

Conference Reporter in Paroxysmal Nocturnal Hemoglobinuria to Cover Key Topics Being Presented at the 64th ASH Annual Meeting and Exposition

conference reporter
By Carlos M. de Castro III, MD; Jaroslaw P. Maciejewski, MD, PhD, FACP; Ronald S. Go, MD
Novel Disease Biomarkers and Artificial Intelligence in Age-Related Macular Degeneration and Geographic Atrophy
Geographic Atrophy

Novel Disease Biomarkers and Artificial Intelligence in Age-Related Macular Degeneration and Geographic Atrophy

conference reporter
By SriniVas R. Sadda, MD, FARVO
Optical Coherence Tomography and Multimodal Diagnostics in Age-Related Macular Degeneration and Geographic Atrophy
Geographic Atrophy

Optical Coherence Tomography and Multimodal Diagnostics in Age-Related Macular Degeneration and Geographic Atrophy

conference reporter
By SriniVas R. Sadda, MD, FARVO
Geographic Atrophy in Age-Related Macular Degeneration: Novel Strategies Targeting the Complement System
Geographic Atrophy

Geographic Atrophy in Age-Related Macular Degeneration: Novel Strategies Targeting the Complement System

conference reporter
By Carl D. Regillo, MD, FACS, FASRS
The Natural History of Age-Related Macular Degeneration and Geographic Atrophy
Geographic Atrophy

The Natural History of Age-Related Macular Degeneration and Geographic Atrophy

conference reporter
By Carl D. Regillo, MD, FACS, FASRS
Potential of Gene Therapy for Age-Related Macular Degeneration
Geographic Atrophy

Potential of Gene Therapy for Age-Related Macular Degeneration

conference reporter
By Peter K. Kaiser, MD
Future Management of Geographic Atrophy in Age-Related Macular Degeneration
Geographic Atrophy

Future Management of Geographic Atrophy in Age-Related Macular Degeneration

conference reporter
By Peter K. Kaiser, MD
Conference Reporter in Geographic Atrophy to Cover Key Topics Being Presented at the 2022 Annual Meeting of the American Academy of Ophthalmology
Geographic Atrophy

Conference Reporter in Geographic Atrophy to Cover Key Topics Being Presented at the 2022 Annual Meeting of the American Academy of Ophthalmology

conference reporter
By Carl D. Regillo, MD, FACS, FASRS; Peter K. Kaiser, MD; SriniVas R. Sadda, MD, FARVO
Earlier-Stage Non–Small Cell Lung Cancer: Immunotherapy Highlights
Immuno-Oncology

Earlier-Stage Non–Small Cell Lung Cancer: Immunotherapy Highlights

conference reporter
By Bruce E. Johnson, MD
Advanced Solid Tumors: New Directions for Checkpoint Blockade
Immuno-Oncology

Advanced Solid Tumors: New Directions for Checkpoint Blockade

conference reporter
By Bruce E. Johnson, MD
Biomarkers of Response to PD-1/PD-L1–Directed Therapy
Immuno-Oncology

Biomarkers of Response to PD-1/PD-L1–Directed Therapy

conference reporter
By Mark G. Kris, MD
Appreciating the Complexity: Immune Escape and Immune-Related Side Effects
Immuno-Oncology

Appreciating the Complexity: Immune Escape and Immune-Related Side Effects

conference reporter
By Mark G. Kris, MD
Precision Immunotherapy and Novel Concepts in Immuno-Oncology
Immuno-Oncology

Precision Immunotherapy and Novel Concepts in Immuno-Oncology

conference reporter
By Julie R. Brahmer, MD, MSc
Established and Emerging Immune Checkpoint Inhibitor Combination Strategies
Immuno-Oncology

Established and Emerging Immune Checkpoint Inhibitor Combination Strategies

conference reporter
By Julie R. Brahmer, MD, MSc
Conference Reporter in Immuno-Oncology to Cover Key Topics Being Presented at the 2022 ASCO Annual Meeting
Immuno-Oncology

Conference Reporter in Immuno-Oncology to Cover Key Topics Being Presented at the 2022 ASCO Annual Meeting

conference reporter
By Bruce E. Johnson, MD; Julie R. Brahmer, MD, MSc; Mark G. Kris, MD
First-in-Class Prospects and New Targets in Advanced Prostate Cancer
Metastatic Prostate Cancer

First-in-Class Prospects and New Targets in Advanced Prostate Cancer

conference reporter
By Christopher J. Logothetis, MD
Treatment Decision Making: Understanding What Matters to Patients With Metastatic Castration-Resistant Prostate Cancer
Metastatic Prostate Cancer

Treatment Decision Making: Understanding What Matters to Patients With Metastatic Castration-Resistant Prostate Cancer

conference reporter
By Christopher J. Logothetis, MD
Predictive and Prognostic Value of Advanced Positron Emission Tomography Imaging
Metastatic Prostate Cancer

Predictive and Prognostic Value of Advanced Positron Emission Tomography Imaging

conference reporter
By Scott T. Tagawa, MD, MS, FACP
Implementing Novel Targeted Radioligand Therapies
Metastatic Prostate Cancer

Implementing Novel Targeted Radioligand Therapies

conference reporter
By Scott T. Tagawa, MD, MS, FACP
Disparities in Prostate Cancer Care
Metastatic Prostate Cancer

Disparities in Prostate Cancer Care

conference reporter
By Judd W. Moul, MD
Biomarker Testing in the Emerging Treatment Era
Metastatic Prostate Cancer

Biomarker Testing in the Emerging Treatment Era

conference reporter
By Judd W. Moul, MD
Chronic Lymphocytic Leukemia: Real-World Data on Testing and Treatment
Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia: Real-World Data on Testing and Treatment

conference reporter
By Anthony R. Mato, MD, MSCE
Investigational Novel-Novel Combinations for Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia

Investigational Novel-Novel Combinations for Chronic Lymphocytic Leukemia

conference reporter
By Anthony R. Mato, MD, MSCE
COVID-19 in Chronic Myeloid Leukemia and Other Hematologic Malignancies
Chronic Myeloid Leukemia

COVID-19 in Chronic Myeloid Leukemia and Other Hematologic Malignancies

conference reporter
By Jorge E. Cortes, MD
Molecular Status for the Discontinuation of Tyrosine Kinase Inhibitor Therapy
Chronic Myeloid Leukemia

Molecular Status for the Discontinuation of Tyrosine Kinase Inhibitor Therapy

conference reporter
By Jorge E. Cortes, MD
Resistance and Persistence in Chronic Myeloid Leukemia
Chronic Myeloid Leukemia

Resistance and Persistence in Chronic Myeloid Leukemia

conference reporter
By Elias Jabbour, MD
Unmet Needs in Chronic Myeloid Leukemia and Insights From Next-Generation Studies
Chronic Myeloid Leukemia

Unmet Needs in Chronic Myeloid Leukemia and Insights From Next-Generation Studies

conference reporter
By Elias Jabbour, MD
Taking a Whole-Patient Approach to Treating Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia

Taking a Whole-Patient Approach to Treating Chronic Lymphocytic Leukemia

conference reporter
By Matthew S. Davids, MD, MMSc
Extending Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia

Extending Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia

conference reporter
By Matthew S. Davids, MD, MMSc
Chronic Lymphocytic Leukemia Treatment Patterns in the Era of Novel Agents
Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia Treatment Patterns in the Era of Novel Agents

conference reporter
By Jan A. Burger, MD, PhD
Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Real-World Data
Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Real-World Data

conference reporter
By Daniel J. DeAngelo, MD, PhD
Important Frontiers in Chronic Myeloid Leukemia Research
Chronic Myeloid Leukemia

Important Frontiers in Chronic Myeloid Leukemia Research

conference reporter
By Daniel J. DeAngelo, MD, PhD
Long-term Survival Data With Preferred Frontline Therapies for Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia

Long-term Survival Data With Preferred Frontline Therapies for Chronic Lymphocytic Leukemia

conference reporter
By Jan A. Burger, MD, PhD
Noninvasive Testing for Fatty Liver Disease and Its Different Phenotypes
Liver Fibrosis

Noninvasive Testing for Fatty Liver Disease and Its Different Phenotypes

conference reporter
By Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD
Multidisciplinary Care for Nonalcoholic Fatty Liver Disease
Liver Fibrosis

Multidisciplinary Care for Nonalcoholic Fatty Liver Disease

conference reporter
By Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD
The Gut-Liver Axis and the Microbiome in Liver Inflammation and Fibrosis
Liver Fibrosis

The Gut-Liver Axis and the Microbiome in Liver Inflammation and Fibrosis

conference reporter
By Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD
Novel Approaches to Detect Liver Disease
Liver Fibrosis

Novel Approaches to Detect Liver Disease

conference reporter
By Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD
Therapies on the Horizon for Nonalcoholic Steatohepatitis
Liver Fibrosis

Therapies on the Horizon for Nonalcoholic Steatohepatitis

conference reporter
By Rohit Loomba, MD, MHSc
Conference Reporter in Chronic Lymphocytic Leukemia to Cover Key Topics Being Presented at the 63rd ASH Annual Meeting and Exposition
Chronic Lymphocytic Leukemia

Conference Reporter in Chronic Lymphocytic Leukemia to Cover Key Topics Being Presented at the 63rd ASH Annual Meeting and Exposition

conference reporter
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Matthew S. Davids, MD, MMSc
Noninvasive Tests to Risk Stratify Patients With Fatty Liver Disease
Liver Fibrosis

Noninvasive Tests to Risk Stratify Patients With Fatty Liver Disease

conference reporter
By Rohit Loomba, MD, MHSc
Conference Reporter in Liver Fibrosis to Cover Key Topics Being Presented at Recent Liver Disease Meeting
Liver Fibrosis

Conference Reporter in Liver Fibrosis to Cover Key Topics Being Presented at Recent Liver Disease Meeting

conference reporter
By Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD; Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD; Rohit Loomba, MD, MHSc
Imaging-Based Patient Selection for Advanced Prostate Cancer Therapies
Metastatic Prostate Cancer

Imaging-Based Patient Selection for Advanced Prostate Cancer Therapies

conference reporter
By Michael S. Cookson, MD, MMHC, FACS
Practice-Changing Radiology and Nuclear Medicine in Advanced Prostate Cancer
Metastatic Prostate Cancer

Practice-Changing Radiology and Nuclear Medicine in Advanced Prostate Cancer

conference reporter
By Michael S. Cookson, MD, MMHC, FACS
Advanced Prostate Cancer: Novel Approaches for Distant Disease
Metastatic Prostate Cancer

Advanced Prostate Cancer: Novel Approaches for Distant Disease

conference reporter
By Robert Dreicer, MD, MS, MACP, FASCO
Biomarker-Driven Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer
Metastatic Prostate Cancer

Biomarker-Driven Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer

conference reporter
By Robert Dreicer, MD, MS, MACP, FASCO
High-Risk Locally Advanced Prostate Cancer: Session Roundup
Advanced Hormone-Sensitive Prostate Cancer

High-Risk Locally Advanced Prostate Cancer: Session Roundup

conference reporter
By Daniel P. Petrylak, MD
Metastatic Hormone-Sensitive Prostate Cancer: Analyses and Emerging Data
Advanced Hormone-Sensitive Prostate Cancer

Metastatic Hormone-Sensitive Prostate Cancer: Analyses and Emerging Data

conference reporter
By Daniel P. Petrylak, MD
Genomic Testing and Predictive Biomarkers in Advanced Prostate Cancer
Metastatic Prostate Cancer

Genomic Testing and Predictive Biomarkers in Advanced Prostate Cancer

conference reporter
By William K. Oh, MD
Clinical Trial Announcements and Studies to Follow
Metastatic Prostate Cancer

Clinical Trial Announcements and Studies to Follow

conference reporter
By William K. Oh, MD
Gonadotropin-Releasing Hormone Agonists and Antagonists: Updates and Considerations
Advanced Hormone-Sensitive Prostate Cancer

Gonadotropin-Releasing Hormone Agonists and Antagonists: Updates and Considerations

conference reporter
By Peter R. Carroll, MD, MPH
Controversies in Urology: Prostate Biopsy Best Practices
Advanced Hormone-Sensitive Prostate Cancer

Controversies in Urology: Prostate Biopsy Best Practices

conference reporter
By Peter R. Carroll, MD, MPH
The Future of Urologic Oncology: Treatment Advances Spur Discussion
Advanced Hormone-Sensitive Prostate Cancer

The Future of Urologic Oncology: Treatment Advances Spur Discussion

conference reporter
By Joseph A. Smith Jr, MD
Guidelines From the Advanced Prostate Cancer Panel
Advanced Hormone-Sensitive Prostate Cancer

Guidelines From the Advanced Prostate Cancer Panel

conference reporter
By Joseph A. Smith Jr, MD
Conference Reporter in Advanced Hormone-Sensitive Prostate Cancer to Cover Key Topics Being Presented at AUA2021
Advanced Hormone-Sensitive Prostate Cancer

Conference Reporter in Advanced Hormone-Sensitive Prostate Cancer to Cover Key Topics Being Presented at AUA2021

conference reporter
By Daniel P. Petrylak, MD; Joseph A. Smith Jr, MD; Peter R. Carroll, MD, MPH
Promise in Treatment Personalization for Advanced Prostate Cancer
Metastatic Prostate Cancer

Promise in Treatment Personalization for Advanced Prostate Cancer

conference reporter
By E. David Crawford, MD
Metastatic Prostate Cancer: Predictive Biomarkers for Tailored Therapy
Metastatic Prostate Cancer

Metastatic Prostate Cancer: Predictive Biomarkers for Tailored Therapy

conference reporter
By E. David Crawford, MD
Novel and Emerging Treatments for Progressive Metastatic Castration-Resistant Prostate Cancer
Metastatic Prostate Cancer

Novel and Emerging Treatments for Progressive Metastatic Castration-Resistant Prostate Cancer

conference reporter
By William K. Oh, MD
Treatment Sequence in Patients With Castration-Resistant Prostate Cancer
Metastatic Prostate Cancer

Treatment Sequence in Patients With Castration-Resistant Prostate Cancer

conference reporter
By William K. Oh, MD
High-Risk and Locally Advanced Prostate Cancer: Clinical Roundup
Metastatic Prostate Cancer

High-Risk and Locally Advanced Prostate Cancer: Clinical Roundup

conference reporter
By Peter R. Carroll, MD, MPH
Prostate-Specific Membrane Antigen–Targeted Therapies: Expert Insights
Metastatic Prostate Cancer

Prostate-Specific Membrane Antigen–Targeted Therapies: Expert Insights

conference reporter
By Peter R. Carroll, MD, MPH
Real-World Care of Patients With Epilepsy
Epilepsy

Real-World Care of Patients With Epilepsy

conference reporter
By Sara Hocker, MD, FAAN
Drug-Resistant Epilepsy and Related Clinical Trials and Registries
Epilepsy

Drug-Resistant Epilepsy and Related Clinical Trials and Registries

conference reporter
By Sara Hocker, MD, FAAN
Aggressive B-Cell Non-Hodgkin Lymphoma: Molecular Profiling and Post-Treatment Surveillance
Aggressive B-Cell Lymphoma

Aggressive B-Cell Non-Hodgkin Lymphoma: Molecular Profiling and Post-Treatment Surveillance

conference reporter
By David Miklos, MD, PhD
Expanding Horizons: Antibody-Based Therapy in Multiple Myeloma
Multiple Myeloma

Expanding Horizons: Antibody-Based Therapy in Multiple Myeloma

conference reporter
By Paul G. Richardson, MD
Novel and Emerging Therapeutic Strategies for Multiple Myeloma
Multiple Myeloma

Novel and Emerging Therapeutic Strategies for Multiple Myeloma

conference reporter
By Paul G. Richardson, MD
Newer and Emerging Therapies for Uncontrolled Focal Seizures
Epilepsy

Newer and Emerging Therapies for Uncontrolled Focal Seizures

conference reporter
By John M. Stern, MD
Optimizing CAR T-Cell Therapy and Durability of Response in Aggressive B-Cell Lymphoma
Aggressive B-Cell Lymphoma

Optimizing CAR T-Cell Therapy and Durability of Response in Aggressive B-Cell Lymphoma

conference reporter
By Frederick L. Locke, MD
Epileptic Syndromes and the Future of Epilepsy Genetics
Epilepsy

Epileptic Syndromes and the Future of Epilepsy Genetics

conference reporter
By John M. Stern, MD
Cellular and Immune-Based Therapies for Relapsed Aggressive B-Cell Lymphoma
Aggressive B-Cell Lymphoma

Cellular and Immune-Based Therapies for Relapsed Aggressive B-Cell Lymphoma

conference reporter
By Frederick L. Locke, MD
Research to Address Unmet Needs in Multiple Myeloma
Multiple Myeloma

Research to Address Unmet Needs in Multiple Myeloma

conference reporter
By S. Vincent Rajkumar, MD
Psychiatric Comorbidity and the Evaluation of Epilepsy
Epilepsy

Psychiatric Comorbidity and the Evaluation of Epilepsy

conference reporter
By Gregory L. Krauss, MD
Frail and/or Older Patients With Multiple Myeloma: ASH 2020 Roundup
Multiple Myeloma

Frail and/or Older Patients With Multiple Myeloma: ASH 2020 Roundup

conference reporter
By S. Vincent Rajkumar, MD
Unmet Treatment Needs in Aggressive B-Cell Lymphoma
Aggressive B-Cell Lymphoma

Unmet Treatment Needs in Aggressive B-Cell Lymphoma

conference reporter
By David Miklos, MD, PhD
Updates on Multiple Myeloma and Immunoglobulin Light Chain Amyloidosis
Multiple Myeloma

Updates on Multiple Myeloma and Immunoglobulin Light Chain Amyloidosis

conference reporter
By Robert Z. Orlowski, MD, PhD
Achieving Seizure Freedom in Patients With Drug-Resistant Epilepsy
Epilepsy

Achieving Seizure Freedom in Patients With Drug-Resistant Epilepsy

conference reporter
By Gregory L. Krauss, MD
Novel and Evolving Therapeutic Constructs in Aggressive B-Cell Lymphoma
Aggressive B-Cell Lymphoma

Novel and Evolving Therapeutic Constructs in Aggressive B-Cell Lymphoma

conference reporter
By Jeremy S. Abramson, MD, MMSc
CAR T-Cell Therapies, Bispecific Antibodies, and Antibody Conjugates
Multiple Myeloma

CAR T-Cell Therapies, Bispecific Antibodies, and Antibody Conjugates

conference reporter
By Robert Z. Orlowski, MD, PhD
Treatment of Double-Hit Lymphomas and Other High-Risk Subsets
Aggressive B-Cell Lymphoma

Treatment of Double-Hit Lymphomas and Other High-Risk Subsets

conference reporter
By Jeremy S. Abramson, MD, MMSc
Conference Reporter in Epilepsy to Cover Key Topics Being Presented at AES2020
Epilepsy

Conference Reporter in Epilepsy to Cover Key Topics Being Presented at AES2020

conference reporter
By Gregory L. Krauss, MD; John M. Stern, MD; Sara Hocker, MD, FAAN
Conference Reporter in Aggressive B-Cell Lymphoma to Cover Key Topics Being Presented at the 62nd ASH Annual Meeting and Exposition
Aggressive B-Cell Lymphoma

Conference Reporter in Aggressive B-Cell Lymphoma to Cover Key Topics Being Presented at the 62nd ASH Annual Meeting and Exposition

conference reporter
By David Miklos, MD, PhD; Frederick L. Locke, MD; Jeremy S. Abramson, MD, MMSc
Conference Reporter in Multiple Myeloma to Cover Key Topics Being Presented at the 62nd ASH Annual Meeting and Exposition
Multiple Myeloma

Conference Reporter in Multiple Myeloma to Cover Key Topics Being Presented at the 62nd ASH Annual Meeting and Exposition

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD
Allaying Parental Concerns About Chemicals in Vaccines
Influenza

Allaying Parental Concerns About Chemicals in Vaccines

conference reporter
By Sean O’Leary, MD, MPH
Visual Indications of Infections and Their Mimickers
Influenza

Visual Indications of Infections and Their Mimickers

conference reporter
By Tina Q. Tan, MD, FAAP, FIDSA, FPIDS
The Red Book Committee: Questions and Answers
Influenza

The Red Book Committee: Questions and Answers

conference reporter
By Mark H. Sawyer, MD, FAAP, FIDSA; Sean O’Leary, MD, MPH
Antimicrobial Update: Current Susceptibility Data and Trends
Influenza

Antimicrobial Update: Current Susceptibility Data and Trends

conference reporter
By Mark H. Sawyer, MD, FAAP, FIDSA
Improving Vaccination Rates and Reducing Vaccine Hesitancy
Influenza

Improving Vaccination Rates and Reducing Vaccine Hesitancy

conference reporter
By Mark H. Sawyer, MD, FAAP, FIDSA; Sean O’Leary, MD, MPH; Tina Q. Tan, MD, FAAP, FIDSA, FPIDS
Changes in Vaccine Recommendations: Review and Updates
Influenza

Changes in Vaccine Recommendations: Review and Updates

conference reporter
By Tina Q. Tan, MD, FAAP, FIDSA, FPIDS
Conference Reporter in Influenza to Cover Key Topics Being Presented at the 2020 AAP Virtual National Conference & Exhibition
Influenza

Conference Reporter in Influenza to Cover Key Topics Being Presented at the 2020 AAP Virtual National Conference & Exhibition

conference reporter
By Mark H. Sawyer, MD, FAAP, FIDSA; Sean O’Leary, MD, MPH; Tina Q. Tan, MD, FAAP, FIDSA, FPIDS
CD38 and Its Expanding Role as an Immunomodulator and Druggable Target
Multiple Myeloma

CD38 and Its Expanding Role as an Immunomodulator and Druggable Target

conference reporter
By Paul G. Richardson, MD
Refractory Multiple Myeloma: Tailoring Treatment to Patient Characteristics
Multiple Myeloma

Refractory Multiple Myeloma: Tailoring Treatment to Patient Characteristics

conference reporter
By S. Vincent Rajkumar, MD
Novel Agents in the Approach to Patients With High-Risk Multiple Myeloma
Multiple Myeloma

Novel Agents in the Approach to Patients With High-Risk Multiple Myeloma

conference reporter
By Robert Z. Orlowski, MD, PhD
Clinical Considerations in Initial Treatment of Newly Diagnosed Patients With Multiple Myeloma
Multiple Myeloma

Clinical Considerations in Initial Treatment of Newly Diagnosed Patients With Multiple Myeloma

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD
Treatment of Patients With Relapsed and/or Refractory and High-Risk Multiple Myeloma
Multiple Myeloma

Treatment of Patients With Relapsed and/or Refractory and High-Risk Multiple Myeloma

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD
Multiple Myeloma Session Roundup: Minimal Residual Disease Assessment and Implications
Multiple Myeloma

Multiple Myeloma Session Roundup: Minimal Residual Disease Assessment and Implications

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD
Conference Reporter in Multiple Myeloma to Cover Key Topics Being Presented at the ASCO20 Virtual Scientific Program and the Virtual Edition of the 25th EHA Annual Congress
Multiple Myeloma

Conference Reporter in Multiple Myeloma to Cover Key Topics Being Presented at the ASCO20 Virtual Scientific Program and the Virtual Edition of the 25th EHA Annual Congress

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD
Managing Pain in Rheumatology: Learning From the Opioid Epidemic
Rheumatoid Arthritis

Managing Pain in Rheumatology: Learning From the Opioid Epidemic

conference reporter
By Leonard H. Calabrese, DO
Nonalcoholic Fatty Liver Disease in Rheumatoid Arthritis and Use of Hepatotoxic Medications
Rheumatoid Arthritis

Nonalcoholic Fatty Liver Disease in Rheumatoid Arthritis and Use of Hepatotoxic Medications

conference reporter
By Leonard H. Calabrese, DO
Patient Management Principles for Difficult-to-Treat Rheumatoid Arthritis
Rheumatoid Arthritis

Patient Management Principles for Difficult-to-Treat Rheumatoid Arthritis

conference reporter
By Alan L. Epstein, MD
Pregnancy in Rheumatoid Arthritis: Principles for Clinical Practice
Rheumatoid Arthritis

Pregnancy in Rheumatoid Arthritis: Principles for Clinical Practice

conference reporter
By Jonathan Kay, MD
Cardiovascular Comorbidity in Rheumatoid Arthritis
Rheumatoid Arthritis

Cardiovascular Comorbidity in Rheumatoid Arthritis

conference reporter
By Alan L. Epstein, MD
Vaccination Strategies for Patients With Rheumatoid Arthritis
Rheumatoid Arthritis

Vaccination Strategies for Patients With Rheumatoid Arthritis

conference reporter
By Jonathan Kay, MD
Conference Reporter in Rheumatoid Arthritis to Cover Key Topics at 2019 ACR/ARP Annual Meeting
Rheumatoid Arthritis

Conference Reporter in Rheumatoid Arthritis to Cover Key Topics at 2019 ACR/ARP Annual Meeting

conference reporter
By Alan L. Epstein, MD; Jonathan Kay, MD; Leonard H. Calabrese, DO
Advertisment